, , , , ,

Romosozumab is the newest agent for treatment of osteoporosis that appears to be far more effective than FOSAMAX (alendronate) and even more effective than Forteo (teriparatide) based on a recent study. It was not compared to the other monoclonal antibody on the market PROLIA possibly because they are both made by the same company.

This medication was given by injection every month and also every three months. A newer drug for osteoporosis has been long overdue and being an injectable given every month or every three months should improve compliance.

Hopefully this drug is priced similar to Prolia and not Forteo which is five times more expensive.

Most effective drug on the market today is still Forteo.